Omega-3 Index

The Omega-3 Gap: Why Most People Are Deficient Without Knowing It

The average Omega-3 Index in the United States is approximately 5% — placing most Americans squarely in the intermediate cardiovascular risk zone. In Northern Europe, average levels are similar. This reflects a fundamental shift in Western dietary patterns over the past century: the near-disappearance of regular fatty fish consumption, the widespread displacement of traditional fats with omega-6-rich vegetable oils, and the reliance on processed food that provides essentially no EPA or DHA.

The contrast with high fish-consuming populations is striking. In Japan, where mackerel, sardines, and salmon are dietary staples, average Omega-3 Index levels are 8–11%. Japan also has some of the lowest rates of cardiovascular disease, sudden cardiac death, and dementia in the developed world — a correlation that has persisted across multiple generations and migration studies. Japanese Americans who adopt Western dietary patterns show converging cardiovascular risk with non-Japanese Americans within a generation — accompanied by declining omega-3 status.

The Omega-3 Index is not a marker most people have encountered. Unlike cholesterol or blood pressure, it is not measured in standard annual physicals and is not part of routine screening panels. Yet the evidence for its cardiovascular significance rivals that of LDL cholesterol — and unlike LDL, it is almost universally low in Western populations and responds reliably to a straightforward intervention.

Why Cell Membrane Omega-3 Matters: Mechanisms of Benefit

EPA and DHA are not just circulating lipids — they are structural components of cell membranes throughout the body. The Omega-3 Index is specifically measured in red blood cell membranes because it reflects the fatty acid composition of cell membranes generally, providing a stable integrated picture of long-term EPA and DHA status.

When EPA and DHA are incorporated into cell membranes at adequate levels, several important effects follow:

Membrane fluidity and function: EPA and DHA are polyunsaturated fatty acids with multiple double bonds, which makes them structurally flexible compared to saturated fats. Membranes with adequate EPA and DHA are more fluid and permeable — facilitating receptor function, ion channel activity, and cellular signaling. Heart muscle cells, neurons, and retinal cells are particularly dependent on high membrane EPA+DHA content for proper function.

Cardiac electrical stability: The most dramatic cardiovascular benefit of omega-3 fatty acids — and the one with the strongest evidence — is reduction in the risk of fatal cardiac arrhythmias and sudden cardiac death. EPA and DHA stabilize cardiac cell membranes and reduce electrical excitability, making dangerous arrhythmias less likely to initiate and propagate. The DART trial (1989) showed a 29% reduction in total mortality with modest fatty fish consumption in men recovering from myocardial infarction — almost entirely driven by reduced sudden death. ¹ Studies of Omega-3 Index levels have found that individuals in the lowest quartile have a 10-fold higher risk of sudden cardiac death compared to those in the highest quartile.

Anti-inflammatory signaling: EPA and DHA are precursors to a family of anti-inflammatory lipid mediators including resolvins, protectins, and maresins — collectively called specialized pro-resolving mediators (SPMs). These compounds actively resolve inflammation rather than merely suppressing it, playing a critical role in returning tissues to homeostasis after injury or immune activation. Low Omega-3 Index is associated with impaired resolution of inflammation — contributing to the chronic low-grade inflammation that drives cardiovascular disease, metabolic dysfunction, and accelerated aging.

Triglyceride reduction: DHA and EPA reduce triglycerides by suppressing hepatic VLDL synthesis and increasing lipoprotein lipase activity. At doses of 2–4 grams EPA+DHA per day, triglyceride reductions of 20–45% are consistently demonstrated. This is one of the few nutritional interventions with FDA-approved pharmaceutical equivalents (Vascepa, Lovaza) for hypertriglyceridemia.

Cognitive and neurological function: DHA is the dominant structural fatty acid in brain gray matter, making up approximately 15–20% of the dry weight of the cerebral cortex. Adequate DHA is essential for synaptogenesis, membrane receptor function, and neuronal survival. Low DHA status in midlife is associated with accelerated brain volume loss, cognitive decline, and increased Alzheimer's disease risk. The brain cannot synthesize DHA from scratch — it must obtain it from dietary sources or de novo conversion from ALA (which is extremely inefficient).

The Omega-3 Index Risk Classification

The Omega-3 Index risk classification was developed by Dr. William Harris and colleagues, who validated it as an independent cardiovascular risk factor comparable in magnitude to other established risk factors. ²

How to Raise Your Omega-3 Index: Fish vs. Supplements

Reaching an Omega-3 Index above 8% requires meaningful, consistent EPA+DHA intake — either from food or from well-chosen supplements. The dose matters significantly.

Food sources

Fatty cold-water fish are by far the richest dietary sources of EPA and DHA. A single 3.5-ounce serving of farmed Atlantic salmon provides approximately 2.0–2.5 grams of EPA+DHA — enough to meaningfully raise the Omega-3 Index with regular consumption. Other high-EPA+DHA sources include mackerel (~2.5 g per serving), sardines (~1.5 g), herring (~2.0 g), anchovies (~2.0 g), and wild Alaskan salmon (~1.5–2.5 g). Three servings per week of fatty fish provides roughly 4.5–7 grams of EPA+DHA weekly, which is sufficient to reach the target for most people.

A practical note: not all fish are equivalent. Tilapia, cod, and other lean white fish contain minimal omega-3s (under 0.3 g per serving). Shrimp and scallops provide modest amounts (0.3–0.5 g per serving). For the Omega-3 Index, only fatty fish consumed regularly makes a meaningful difference.

Supplements

For people who don't eat fatty fish regularly — whether by preference, access, or concern about contaminants — supplements are highly effective. The critical variable is the dose of actual EPA+DHA, not the total "fish oil" content on the label.

• What to look for: Find the combined EPA+DHA content per serving on the supplement facts panel. Target 2–3 grams of combined EPA+DHA per day to reliably move the Omega-3 Index toward the target range.
• Standard fish oil capsules: Most 1000 mg softgels contain only 180 mg EPA + 120 mg DHA = 300 mg combined EPA+DHA. You would need 6–10 of these per day to reach the target dose. High-potency fish oil products concentrate EPA+DHA to 600–900 mg per capsule, requiring 2–4 capsules per day.
• Form matters: Re-esterified triglyceride (rTG) form has 70% higher bioavailability than ethyl ester (EE) form, which is common in cheaper products. Phospholipid forms (krill oil) also have high bioavailability but are more expensive per gram of EPA+DHA. For maximum efficacy per dollar, high-concentration rTG fish oil is typically the best choice.
• Algae-based omega-3: For vegetarians and vegans, algae oil provides EPA and DHA directly (bypassing the fish entirely — fish get their omega-3s from algae). High-quality algae oil supplements provide 500–1000 mg EPA+DHA per serving and are equally effective at raising the Omega-3 Index.
• Purity: Look for supplements that have been third-party tested for PCBs, heavy metals, and oxidation products. The International Fish Oil Standards (IFOS) certification and NSF certification are reliable quality indicators.

Omega-3 and the Brain: The Cognitive Aging Connection

While the cardiovascular evidence for omega-3 fatty acids is the most extensively studied, the cognitive aging data is compelling and increasingly the focus of longevity medicine attention.

DHA constitutes approximately 15–20% of the dry weight of the cerebral cortex and is the dominant fatty acid in synaptic membranes and photoreceptors. Unlike cholesterol, which the brain can synthesize endogenously, DHA must be obtained from dietary sources or peripheral conversion from ALA — a process too inefficient to meet brain needs adequately. The brain is therefore dependent on circulating DHA for maintenance and repair throughout life.

Longitudinal studies have found that lower Omega-3 Index and lower plasma DHA in midlife predict faster brain volume loss, cognitive decline, and dementia onset decades later. A landmark imaging study found that participants in the lowest quartile of DHA had significantly smaller hippocampal volume, poorer abstract reasoning, and higher white matter lesion burden than those in the highest quartile — differences that persisted after adjusting for other cardiovascular and metabolic risk factors. ³

The neurological benefits of maintaining adequate Omega-3 Index extend to mood: low omega-3 status is associated with increased depression, anxiety, and stress reactivity. EPA in particular has robust evidence for antidepressant effects, with meta-analyses showing EPA-dominant formulations comparable to antidepressant medications for mild-to-moderate depression.

How to Test the Omega-3 Index

The Omega-3 Index is measured from a standard blood draw and does not require fasting. Results are reported as a percentage of total red blood cell fatty acids — specifically the sum of EPA and DHA. The validated commercial test methodology is the HS-Omega-3 Index (developed by OmegaQuant), which provides the most standardized and reproducible measurement.

The Omega-3 Index is not included in standard lipid panels or metabolic panels — it must be specifically ordered. It is available through several direct-access testing services without a doctor's visit, and through comprehensive longevity panels from InsideTracker and InsideTracker.

Testing cadence: Because the Omega-3 Index reflects 90–120 days of red blood cell membrane composition, testing more frequently than every 3–4 months provides little additional signal. The recommended approach for someone trying to improve their index:

1. Test baseline Omega-3 Index
2. Implement consistent dietary or supplementation changes targeting 2–3 g EPA+DHA per day
3. Retest at 4 months to assess response
4. Adjust dose if target not yet reached
5. Once above 8%, annual retesting is sufficient

The Omega-3 Index is one of the few longevity biomarkers where the intervention is clear, the dose is well-defined, the response is predictable, and the risk of overcorrection is essentially zero at reasonable supplementation doses. It is also one of the lowest-hanging fruit in longevity medicine — a nearly universal deficiency with a straightforward, inexpensive correction.

Sources

1. Burr ML, et al. "Effects on Death Rate Amongst 2033 Men with Coronary Heart Disease." The Lancet, 1989. PubMed →
2. Harris WS, von Schacky C. "The Omega-3 Index: A New Risk Factor for Death from Coronary Heart Disease?" Preventive Medicine, 2004. PubMed →
3. Tan ZS, et al. "Red Blood Cell Omega-3 Fatty Acid Levels and Markers of Accelerated Brain Aging." Neurology, 2012. PubMed →